Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)
Contact +33 (0)3 90 20 54 70

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
  • Wide range of unique reagents
  • Free Shipping
    Free shipping in EU on Orders > €500
  • Fast worldwide delivery
    Fast worldwide delivery
Nycodenz AG® Nycodenz AG® XtenCHO ™ Race Starter kit XtenCHO ™ Race Starter kit
View all Products

Aducanumab Biosimilar – Anti-APP Abeta mAb – Research Grade

Reference:
Size

100ug, 1MG
Isotype

IgG1, kappa
Brand

ProteoGenix
Product type

Primary Antibodies
Clonality

Monoclonal Antibody
Expression system

Mammalian cells
Applications

Elisa, WB
Tags:
Specification
Description
Documents
Publications
Reviews
Product nameAducanumab Biosimilar - Anti-APP Abeta mAb - Research Grade
SourceCAS 1384260-65-4
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery lead time in business days3-5 days if in stock; 3-5 weeks if production needed
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsAducanumab,BART,BIIB-037,APP Abeta,anti-APP Abeta
ReferencePX-TA1335
NoteFor research use only. Not suitable for human use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Aducanumab Biosimilar - Anti-APP Abeta mAb - Research Grade

General information on Anti-APP Abeta[Homo sapiens] (Aducanumab) Monoclonal Antibody

Aducanumab has been investigated for the treatment of Alzheimer’s Disease.

Datasheet Download
MSDS Download

Publication

  • Juul-Madsen, K., Parbo, P., Ismail, R. et al. Amyloid-β aggregates activate peripheral monocytes in mild cognitive impairment. Nat Commun 15, 1224 (2024). https://doi.org/10.1038/s41467-024-45627-y
  • Epitope Sequence and Modification Fingerprints of Anti-Aβ Antibodies, Ivan Talucci, Timon Leske, Hans-Wolfgang Klafki, Mohammed Mehedi Hassan, Annik Steiert, Barbara Morgado, Sebastian Bothe, Lars van Werven, Thomas Liepold, Jochen Walter, Hermann Schindelin, Jens Wiltfang, Oliver Wirths, Olaf Jahn, Hans-Michael Maric, bioRxiv 2025.02.26.640323; doi: https://doi.org/10.1101/2025.02.26.640323
  • Jeong, J., Han, M., Jeon, S. et al. Aducanumab delivery via focused ultrasound-induced transient blood–brain barrier opening in vivo. Sci Rep 15, 17742 (2025). https://doi.org/10.1038/s41598-025-02412-1

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Aducanumab Biosimilar – Anti-APP Abeta mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Human APP (18-690) Recombinant Protein
Antigen

Human APP (18-690) Recombinant Protein

PX-P1058 210€
View product
Human APP (18-705) Recombinant Protein
Antigen

Human APP (18-705) Recombinant Protein

PX-P1059 210€
View product
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 180€
View product

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.

    Cart (0 Items)

    Your cart is currently empty.

    View Products